Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene, bluebird revise deal to co-develop CAR-T therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Submitted by
admin
on March 29, 2018 - 11:33am
Source:
Biopharma Dive
News Tags:
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Headline:
Celgene, bluebird revise deal to co-develop CAR-T therapy
Do Not Allow Advertisers to Use My Personal information
